These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Sclerostin is a direct target of osteoblast-specific transcription factor osterix. Yang F; Tang W; So S; de Crombrugghe B; Zhang C Biochem Biophys Res Commun; 2010 Oct; 400(4):684-8. PubMed ID: 20816666 [TBL] [Abstract][Full Text] [Related]
48. Transcriptional regulation of bone sialoprotein gene expression by Osx. Yang Y; Huang Y; Zhang L; Zhang C Biochem Biophys Res Commun; 2016 Aug; 476(4):574-579. PubMed ID: 27261434 [TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. Lian N; Lin T; Liu W; Wang W; Li L; Sun S; Nyman JS; Yang X J Biol Chem; 2012 Oct; 287(43):35975-84. PubMed ID: 22952236 [TBL] [Abstract][Full Text] [Related]
50. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. Piscopo DM; Johansen EB; Derynck R J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027 [TBL] [Abstract][Full Text] [Related]
51. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866 [TBL] [Abstract][Full Text] [Related]
52. Wdr5 is essential for osteoblast differentiation. Zhu ED; Demay MB; Gori F J Biol Chem; 2008 Mar; 283(12):7361-7. PubMed ID: 18201971 [TBL] [Abstract][Full Text] [Related]
53. Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. Lian N; Wang W; Li L; Elefteriou F; Yang X J Biol Chem; 2009 Oct; 284(44):30518-25. PubMed ID: 19726676 [TBL] [Abstract][Full Text] [Related]
54. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847 [TBL] [Abstract][Full Text] [Related]
56. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Dai YS; Xu J; Molkentin JD Mol Cell Biol; 2005 Nov; 25(22):9936-48. PubMed ID: 16260608 [TBL] [Abstract][Full Text] [Related]
57. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
58. Integrin mediated adhesion of osteoblasts to connective tissue growth factor (CTGF/CCN2) induces cytoskeleton reorganization and cell differentiation. Hendesi H; Barbe MF; Safadi FF; Monroy MA; Popoff SN PLoS One; 2015; 10(2):e0115325. PubMed ID: 25714841 [TBL] [Abstract][Full Text] [Related]
59. Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation. Tang W; Li Y; Osimiri L; Zhang C J Biol Chem; 2011 Sep; 286(38):32995-3002. PubMed ID: 21828043 [TBL] [Abstract][Full Text] [Related]
60. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Ducy P; Karsenty G Mol Cell Biol; 1995 Apr; 15(4):1858-69. PubMed ID: 7891679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]